Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Latest News and Updates |
|
|
|
|
A Gene Causing Persistent Pain Discovered By Oxford Team
According to the most recent research, any medication that can increase the activity of NCX3 has the potential to reduce the pain sensitivity faced by people.
|
|
|
| |
|
Blood Vessel Breakthrough Helps Treatment of Alzheimer's
By showing how exactly Alzheimers affects small blood vessels, new research can be termed as breakthrough to being close to the exact treatment of the disease.
|
|
|
| |
| |
|
|
|
Aquatic Millirobot From Stanford Rolls, Flips, And Spins
These fingertip-sized robots have the ability to save lives in the future by crawling, spinning, and swimming into tight locations and also distribute drugs.
|
|
|
| |
|
Sydney Applauds NSW Financing For Biomedical Research
Being hospital-university ecosystem, SBA will bring global cluster of biomedical research talent and facilities and will be positioned for industry, start-ups.
|
|
|
|
|
| |
|
|
|
Third Rock Raises $1Bn In Life Sciences Amid Biotech Slump
Third Rock Ventures has decided to go ahead with a whopping $1bn funding in the biotech landscape despite the consistent slump which the sector is witnessing.
|
|
| | |
|
|
COVID-19 Updates |
|
|
FDA Has Approved Pfizer, Moderna COVID-19 Shots For Kids
The FDA approved Pfizer and Moderna COVID-19 injections for kids as young as six months old, a decision that parents, carers, and doctors had been waiting for.
|
|
|
| |
| |
|
|
|
Bharat Biotech Ends Clinical Trial Of Nasal COVID-19 Vaccine
Following the completion of clinical trials, the data analysis of the nasal vaccine is currently on after which they shall seek the permission to launch it.
|
|
|
| |
|
Pfizer To Buy 8.1% Equity In Valneva, A French Vaccine Firm
To finance the phase 3 development commitment to its lyme disease program, Valneva intends to use proceeds from the equity investment that is made by Pfizer.
|
|
|
|
|